go 6976 has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villar, J | 1 |
| Quadri, HS | 1 |
| Song, I | 1 |
| Tomita, Y | 1 |
| Tirado, OM | 1 |
| Notario, V | 1 |
| Jaggi, M | 1 |
| Rao, PS | 1 |
| Smith, DJ | 1 |
| Wheelock, MJ | 1 |
| Johnson, KR | 1 |
| Hemstreet, GP | 1 |
| Balaji, KC | 1 |
2 other studies available for go 6976 and Cancer of Prostate
| Article | Year |
|---|---|
PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Res | 2009 |
E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
Topics: Cadherins; Carbazoles; Cell Aggregation; Cell Line, Tumor; Cell Movement; Green Fluorescent Proteins | 2005 |